These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 10481831)

  • 21. Dose response of arginine vasopressin to the CCK-B agonist pentagastrin.
    Abelson JL; Le Mellédo J; Bichet DG
    Neuropsychopharmacology; 2001 Feb; 24(2):161-9. PubMed ID: 11120398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin.
    Khan S; Liberzon I; Abelson JL
    Psychiatry Res; 2004 May; 126(3):189-95. PubMed ID: 15157745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects.
    Abelson JL; Liberzon I; Young EA; Khan S
    Arch Gen Psychiatry; 2005 Jun; 62(6):668-75. PubMed ID: 15939844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition.
    Abelson JL; Young EA
    Psychoneuroendocrinology; 2003 Feb; 28(2):169-80. PubMed ID: 12510010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of propranolol on symptom and endocrine responses to pentagastrin.
    Khan S; Liberzon I; Abelson JL
    Psychoneuroendocrinology; 2004 Oct; 29(9):1163-71. PubMed ID: 15219640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin.
    Abelson JL; Liberzon I
    Neuropsychopharmacology; 1999 Oct; 21(4):485-94. PubMed ID: 10481831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL; Khan S; Liberzon I; Young EA
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the panic attack activate the hypothalamic-pituitary-adrenal axis?
    Graeff FG; Garcia-Leal C; Del-Ben CM; Guimarães FS
    An Acad Bras Cienc; 2005 Sep; 77(3):477-91. PubMed ID: 16127553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCK in anxiety and cognitive processes.
    Daugé V; Léna I
    Neurosci Biobehav Rev; 1998 Oct; 22(6):815-25. PubMed ID: 9809313
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.